购物车
- 全部删除
- 您的购物车当前为空
BF-168 is a candidate probe for PET and specifically recognizes both neuritic and diffuse plaques (Ki: 6.4 nM for Aβ1-42).
为众多的药物研发团队赋能,
让新药发现更简单!
BF-168 is a candidate probe for PET and specifically recognizes both neuritic and diffuse plaques (Ki: 6.4 nM for Aβ1-42).
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
2 mg | ¥ 2,120 | 5日内发货 | |
5 mg | ¥ 3,160 | 5日内发货 | |
25 mg | ¥ 11,400 | 10-14周 | |
50 mg | ¥ 14,900 | 10-14周 | |
100 mg | ¥ 23,700 | 10-14周 |
产品描述 | BF-168 is a candidate probe for PET and specifically recognizes both neuritic and diffuse plaques (Ki: 6.4 nM for Aβ1-42). |
靶点活性 | β-Amyloid (1–42):ki: 6.4 nM |
体外活性 | BF-168 is a potent agent that selectively recognizes SPs and NFTs in AD brain. BF-168 is a candidate probe for PET and is found to specifically recognize both neuritic and diffuse plaques. |
体内活性 | Intravenous injection of BF-168 in PS1/APP and APP23 transgenic mice results in specific in vivo labeling to both compact and diffuse amyloid deposits in the brain. In addition, 18F-radiolabeled BF-168 demonstrates abundant initial brain uptake (3.9% injected dose/gm at 2 min after injection) and fast clearance (t1/2=24.7 min) after intravenous administration in normal mice. |
分子量 | 312.34 |
分子式 | C18H17FN2O2 |
CAS No. | 634911-47-0 |
密度 | 1.258 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容